NCT02046434View on ClinicalTrials.gov

Phenylbutyrate Response as a Biomarker for Alpha-synuclein Clearance From the Brain

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Parkinson's Disease
Interventions
DRUG

Glycerol Phenylbutyrate

Trial Locations (1)

80045

University of Colorado Denver Anschutz Medical Center, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02046434 - Phenylbutyrate Response as a Biomarker for Alpha-synuclein Clearance From the Brain | Biotech Hunter | Biotech Hunter